Sera Prognostics Company
Sera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia, and other pregnancy complications.
Investors
.png)
Headquarters:
Salt Lake City, Utah, United States
Number Of Exists:
Series D
Total Funding:
$250,324,197
Founded Date:
01-01-2008
Employee Number:
51-100
Investment Stage:
N/A
Last Funding Type:
Series E
Investor Type:
Company
Investors Number:
13
Last Funding Date:
2021-04-28
Technology:
Pregnancy biomarkers
Funding Status:
IPO
Estimated Revenue:
$10M to $50M
Industry:
Pregnancy & Nursing